Asbjørg Stray‐Pedersen

8.4k total citations · 1 hit paper
55 papers, 1.9k citations indexed

About

Asbjørg Stray‐Pedersen is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Asbjørg Stray‐Pedersen has authored 55 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 18 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in Asbjørg Stray‐Pedersen's work include Immunodeficiency and Autoimmune Disorders (12 papers), Genomics and Rare Diseases (10 papers) and Genomic variations and chromosomal abnormalities (8 papers). Asbjørg Stray‐Pedersen is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (12 papers), Genomics and Rare Diseases (10 papers) and Genomic variations and chromosomal abnormalities (8 papers). Asbjørg Stray‐Pedersen collaborates with scholars based in Norway, United States and Netherlands. Asbjørg Stray‐Pedersen's co-authors include Marc A. Gavin, Paul deRoos, Evan Houston, Troy R. Torgerson, Hans D. Ochs, Philip D. Greenberg, William Ho, Alexander Y. Rudensky, Anne Kjersti Erichsen and Chantal Tallaksen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Asbjørg Stray‐Pedersen

49 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development

2006 640 citations Marc A. Gavin, Troy R. Torgerson et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Asbjørg Stray‐Pedersen Norway	22	865	516	371	229	204	55	1.9k
Julie Wheway Australia	14	1.4k 1.6×	352 0.7×	275 0.7×	206 0.9×	96 0.5×	15	2.5k
Masaaki Niino Japan	30	1.3k 1.5×	661 1.3×	206 0.6×	172 0.8×	213 1.0×	140	3.3k
Evan M. Braunstein United States	19	612 0.7×	1.1k 2.1×	591 1.6×	109 0.5×	154 0.8×	51	2.5k
Elísabet Einarsdóttir Sweden	23	378 0.4×	501 1.0×	398 1.1×	172 0.8×	141 0.7×	71	1.6k
Sarah L. Davies United Kingdom	22	825 1.0×	926 1.8×	285 0.8×	187 0.8×	322 1.6×	63	2.5k
Richard N. Hanna United States	22	1.9k 2.2×	801 1.6×	304 0.8×	373 1.6×	240 1.2×	28	3.1k
Benjamin P. Fairfax United Kingdom	24	1.2k 1.4×	1.1k 2.1×	637 1.7×	229 1.0×	251 1.2×	54	2.8k
Rebecca Newton Australia	21	1.6k 1.9×	912 1.8×	139 0.4×	200 0.9×	162 0.8×	30	2.7k
Claire Usal France	30	1.3k 1.5×	914 1.8×	427 1.2×	57 0.2×	105 0.5×	67	2.7k
Paul T. Massa United States	27	1.2k 1.4×	824 1.6×	188 0.5×	197 0.9×	225 1.1×	63	2.4k

Countries citing papers authored by Asbjørg Stray‐Pedersen

Since Specialization

Citations

This map shows the geographic impact of Asbjørg Stray‐Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asbjørg Stray‐Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asbjørg Stray‐Pedersen more than expected).

Fields of papers citing papers by Asbjørg Stray‐Pedersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asbjørg Stray‐Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asbjørg Stray‐Pedersen. The network helps show where Asbjørg Stray‐Pedersen may publish in the future.

Co-authorship network of co-authors of Asbjørg Stray‐Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of Asbjørg Stray‐Pedersen. A scholar is included among the top collaborators of Asbjørg Stray‐Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asbjørg Stray‐Pedersen. Asbjørg Stray‐Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baliakas, Panagiotis, Bianca Tesi, Jörg Cammenga, et al.. (2024). How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms. HemaSphere. 8(8). e145–e145. 3 indexed citations

Fang, Evandro Fei, et al.. (2023). Long‐Term Nicotinamide Riboside Use Improves Coordination and Eye Movements in Ataxia Telangiectasia. Movement Disorders. 39(2). 360–369. 22 indexed citations

Helverschou, Sissel Berge, et al.. (2023). Personalised medicine for developmental disorders. Tidsskrift for Den norske legeforening. 143(13).

Hogner, Silje, et al.. (2023). Newborn Genetic Screening—Still a Role for Sanger Sequencing in the Era of NGS. International Journal of Neonatal Screening. 9(4). 67–67. 2 indexed citations

Jørgensen, Silje F., Jochen Buechner, Anders Eivind Myhre, et al.. (2021). A Nationwide Study of GATA2 Deficiency in Norway—the Majority of Patients Have Undergone Allo-HSCT. Journal of Clinical Immunology. 42(2). 404–420. 10 indexed citations

Baliakas, Panagiotis, Bianca Tesi, Ulla Wartiovaara‐Kautto, et al.. (2019). Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up. HemaSphere. 3(6). e321–e321. 53 indexed citations

Knaus, Alexej, Fanny Kortüm, Tjitske Kleefstra, et al.. (2019). Mutations in PIGU Impair the Function of the GPI Transamidase Complex, Causing Severe Intellectual Disability, Epilepsy, and Brain Anomalies. The American Journal of Human Genetics. 105(2). 395–402. 35 indexed citations

Artaç, Hasibe, et al.. (2019). Infliximab therapy for inflammatory colitis in an infant with NEMO deficiency. Immunologic Research. 67(4-5). 450–453. 6 indexed citations

Skogseid, Inger Marie, Oddveig Røsby, Ane Konglund, et al.. (2018). Dystonia-deafness syndrome caused by ACTB p.Arg183Trp heterozygosity shows striatal dopaminergic dysfunction and response to pallidal stimulation. Journal of Neurodevelopmental Disorders. 10(1). 17–17. 21 indexed citations

10.

Samarakoon, Pubudu, Hanne Sørmo Sorte, Asbjørg Stray‐Pedersen, et al.. (2016). cnvScan: a CNV screening and annotation tool to improve the clinical utility of computational CNV prediction from exome sequencing data. BMC Genomics. 17(1). 51–51. 20 indexed citations

11.

Prescott, Trine, Mari Ann Kulseth, Ketil Heimdal, et al.. (2016). Two male sibs with severe micrognathia and a missense variant in MED12. European Journal of Medical Genetics. 59(8). 367–372. 8 indexed citations

12.

Rognum, TO, Sigve Holmen, Maja Musse, et al.. (2016). Estimation of time since death by vitreous humor hypoxanthine, potassium, and ambient temperature. Forensic Science International. 262. 160–165. 47 indexed citations

13.

Stray‐Pedersen, Asbjørg, Jan-Maarten Cobben, Trine Prescott, et al.. (2015). Biallelic Mutations in UNC80 Cause Persistent Hypotonia, Encephalopathy, Growth Retardation, and Severe Intellectual Disability. The American Journal of Human Genetics. 98(1). 202–209. 35 indexed citations

14.

Sorte, Hanne Sørmo, Lars Mørkrid, Olaug K. Rødningen, et al.. (2012). Severe ALG8-CDG (CDG-Ih) associated with homozygosity for two novel missense mutations detected by exome sequencing of candidate genes. European Journal of Medical Genetics. 55(3). 196–202. 12 indexed citations

15.

Glosli, Heidi, Asbjørg Stray‐Pedersen, Tone Tønjum, et al.. (2008). Infections Due to Various Atypical Mycobacteria in a Norwegian Multiplex Family with Dominant Interferon- Receptor Deficiency. Clinical Infectious Diseases. 46(3). e23–e27. 22 indexed citations

16.

Stray‐Pedersen, Arne, et al.. (2007). Post‐Neonatal drop in alveolar SP‐A expression: Biological significance for increased vulnerability to SIDS?. Pediatric Pulmonology. 43(2). 160–168. 6 indexed citations

17.

Riise, Ruth, Jan Ygge, Asbjørg Stray‐Pedersen, et al.. (2007). Ocular findings in Norwegian patients with ataxia‐telangiectasia: a 5 year prospective cohort study. Acta Ophthalmologica Scandinavica. 85(5). 557–562. 16 indexed citations

18.

Gavin, Marc A., Troy R. Torgerson, Evan Houston, et al.. (2006). Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proceedings of the National Academy of Sciences. 103(17). 6659–6664. 640 indexed citations breakdown →

19.

Stray‐Pedersen, Asbjørg, et al.. (2003). Kronisk nøytropeni – inndeling og behandling. Tidsskrift for Den Norske Laegeforening.

20.

Stray‐Pedersen, Asbjørg, et al.. (2000). Primary Immunodeficiency Diseases in Norway. Journal of Clinical Immunology. 20(6). 477–485. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact